Update catalog format (#316)

edelarua · web-flow · commit 881fab692265 · 2025-09-09T10:30:46.000-04:00
diff --git a/quarto/assets/images/image-placeholder.png b/quarto/assets/images/image-placeholder.png
diff --git a/quarto/catalog/fda-table_02/index.qmd b/quarto/catalog/fda-table_02/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 02
-subtitle: Demographics and Baseline Clinical Characteristics, Safety Population, Pooled Analysis (or Trial X)
+title: Demographics and Baseline Clinical Characteristics, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 02
 categories: [table, FDA, safety, demographics]
 ---
 
diff --git a/quarto/catalog/fda-table_03/index.qmd b/quarto/catalog/fda-table_03/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 03
-subtitle: Subject Screening and Enrollment, Screening Population, Trials A and B
+title: Subject Screening and Enrollment, Screening Population, Trials A and B
+subtitle: FDA Table 03
 categories: [table, FDA, safety, disposition]
 ---
 
diff --git a/quarto/catalog/fda-table_04/index.qmd b/quarto/catalog/fda-table_04/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 04
-subtitle: Subject Populations, Randomized Population, Pooled Analysis (or Trial X) 
+title: Subject Populations, Randomized Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 04
 categories: [table, FDA, safety, disposition]
 ---
 
diff --git a/quarto/catalog/fda-table_06/index.qmd b/quarto/catalog/fda-table_06/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 06
-subtitle: Duration of Treatment Exposure, Safety Population, Pooled Analysis (or Trial X)
+title: Duration of Treatment Exposure, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 06
 categories: [table, FDA, safety, exposure]
 ---
 
diff --git a/quarto/catalog/fda-table_07/index.qmd b/quarto/catalog/fda-table_07/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 07
-subtitle: Overview of Adverse Events, Safety Population, Pooled Analysis (or Trial X) 
+title: Overview of Adverse Events, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 07
 categories: [table, FDA, safety, adverse events] 
 ---
 
diff --git a/quarto/catalog/fda-table_08/index.qmd b/quarto/catalog/fda-table_08/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 08
-subtitle: Deaths, Safety Population, Pooled Analysis (or Trial X) 
+title: Deaths, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 08
 categories: [table, FDA, safety, deaths]
 ---
 
diff --git a/quarto/catalog/fda-table_09/index.qmd b/quarto/catalog/fda-table_09/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 09
-subtitle: All Individual Subject Deaths, Safety Population, Pooled Analysis (or Trial X) 
+title: All Individual Subject Deaths, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 09
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_10/index.qmd b/quarto/catalog/fda-table_10/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 10
-subtitle: Subjects With Serious Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Serious Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 10
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_11/index.qmd b/quarto/catalog/fda-table_11/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 11
-subtitle: Subjects With Serious Adverse Events by Organ System and OCMQ (Narrow), Safety Population, Pooled Analysis (or Trial X) 
+title: Subjects With Serious Adverse Events by Organ System and OCMQ (Narrow), Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 11
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_12/index.qmd b/quarto/catalog/fda-table_12/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 12
-subtitle: Subjects With Adverse Events Leading to Treatment Discontinuation by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X) 
+title: Subjects With Adverse Events Leading to Treatment Discontinuation by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 12
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_13/index.qmd b/quarto/catalog/fda-table_13/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 13
-subtitle: Subjects With Adverse Events Leading to Treatment Discontinuation by Organ System and OCMQ (Narrow), Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events Leading to Treatment Discontinuation by Organ System and OCMQ (Narrow), Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 13
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_14/index.qmd b/quarto/catalog/fda-table_14/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 14
-subtitle: Subjects With Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 14
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_15/index.qmd b/quarto/catalog/fda-table_15/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 15
-subtitle: Subjects With Common Adverse Events Occurring at ≥X% Frequency by Preferred Term, Safety Population, Pooled Analysis (or Trial X) 
+title: Subjects With Common Adverse Events Occurring at ≥X% Frequency by Preferred Term, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 15
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_17/index.qmd b/quarto/catalog/fda-table_17/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 17
-subtitle: Subjects With Adverse Events by Organ System and OCMQ, Safety Population, Pooled Analysis (or Trial X) 
+title: Subjects With Adverse Events by Organ System and OCMQ, Safety Population, Pooled Analysis (or Trial X) 
+subtitle: FDA Table 17
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_18/index.qmd b/quarto/catalog/fda-table_18/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 18
-subtitle: Summary Assessment of [Insert AE of Interest], Safety Population, Pooled Analysis (or Trial X)
+title: Summary Assessment of [Insert AE of Interest], Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 18
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_29/index.qmd b/quarto/catalog/fda-table_29/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 29
-subtitle: Subjects With Serious Adverse Events by Organ System, OCMQ (Narrow) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Serious Adverse Events by Organ System, OCMQ (Narrow) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 29
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_33/index.qmd b/quarto/catalog/fda-table_33/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 33
-subtitle: Subjects With Adverse Events by Male-Specific OCMQ (Narrow) and Preferred Term, Male Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by Male-Specific OCMQ (Narrow) and Preferred Term, Male Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 33
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_34/index.qmd b/quarto/catalog/fda-table_34/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 34
-subtitle: Subjects With Adverse Events by Female-Specific OCMQ (Narrow) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by Female-Specific OCMQ (Narrow) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 34
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_36/index.qmd b/quarto/catalog/fda-table_36/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 36
-subtitle: Subjects With Maximum Postbaseline Systolic Blood Pressure by Category of Blood Pressure, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Maximum Postbaseline Systolic Blood Pressure by Category of Blood Pressure, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 36
 categories: [table, FDA, safety, vital signs]
 ---
 
diff --git a/quarto/catalog/fda-table_37/index.qmd b/quarto/catalog/fda-table_37/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 37
-subtitle: Subjects With Maximum Postbaseline Diastolic Blood Pressure by Category of Blood Pressure, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Maximum Postbaseline Diastolic Blood Pressure by Category of Blood Pressure, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 37
 categories: [table, FDA, safety, vital signs]
 ---
 
diff --git a/quarto/catalog/fda-table_38/index.qmd b/quarto/catalog/fda-table_38/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 38
-subtitle: Subjects Meeting Specific Postbaseline Hypotension Levels, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects Meeting Specific Postbaseline Hypotension Levels, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 38
 categories: [table, FDA, safety, vital signs]
 ---
 
diff --git a/quarto/catalog/fda-table_43/index.qmd b/quarto/catalog/fda-table_43/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 43
-subtitle: Subjects With Adverse Events by Organ System, OCMQ (Broad) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by Organ System, OCMQ (Broad) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 43
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_44/index.qmd b/quarto/catalog/fda-table_44/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 44
-subtitle: Subjects With Adverse Events by Male-Specific OCMQ (Broad) and Preferred Term, Male Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by Male-Specific OCMQ (Broad) and Preferred Term, Male Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 44
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_45/index.qmd b/quarto/catalog/fda-table_45/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 45
-subtitle: Subjects With Adverse Events by Female-Specific OCMQ (Broad) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)
+title: Subjects With Adverse Events by Female-Specific OCMQ (Broad) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 45
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/catalog/fda-table_50/index.qmd b/quarto/catalog/fda-table_50/index.qmd
@@ -1,6 +1,6 @@
 ---
-title: FDA Table 50
-subtitle: Overview of Serious Adverse Events by Demographic Subgroup, Safety Population, Pooled Analysis (or Trial X)
+title: Overview of Serious Adverse Events by Demographic Subgroup, Safety Population, Pooled Analysis (or Trial X)
+subtitle: FDA Table 50
 categories: [table, FDA, safety, adverse events]
 ---
 
diff --git a/quarto/index-catalog.qmd b/quarto/index-catalog.qmd
@@ -2,12 +2,15 @@
 title: "Template Catalog"
 listing:
   contents: "catalog/*/index.qmd"
-  type: grid
-  image-placeholder: assets/images/image-placeholder.png
+  type: table
+  table-hover: true
   categories: true
-  fields: [image, title, subtitle, categories]
-  sort-ui: false
+  sort: true
+  fields: [title, subtitle, categories]
+  sort-ui: [subtitle, title]
   filter-ui: [title, subtitle, categories]
-title-block-banner: true
+  field-display-names:
+    title: "TLG Description"
+    subtitle: "Source"
 ---
 
